CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Medically unfit women with early-stage endometrial cancer treated with the levonorgestrel intrauterine system
Manolis Nikolopoulos, Michelle A.L. Godfrey, Rekha Wuntakal
Obstet Gynecol Sci. 2020;63(3):337-345.   Published online March 24, 2020

Excel Download

Correction of Phrase: Medically unfit women with earlystage endometrial cancer treated with the levonorgestrel intrauterine system
Obstetrics & Gynecology Science. 2020;63(4):550-550   Crossref logo
Link1 Link2 Link3

The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
Journal of Gynecologic Oncology. 2019;30(4):   Crossref logo
Link1 Link2 Link3

Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer
Gynecologic Oncology. 2013;130(3):470-473   Crossref logo
Link1 Link2

Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women
Gynecologic Oncology. 2017;146(1):34-38   Crossref logo
Link1 Link2

Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system
Journal of Gynecologic Oncology. 2017;28(1):   Crossref logo
Link1 Link2 Link3

Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen: A cochrane review summary
Maturitas. 2016;89:1-2   Crossref logo
Link1 Link2

Combined medroxyprogesterone acetate/levonorgestrel–intrauterine system treatment in young women with early-stage endometrial cancer
American Journal of Obstetrics and Gynecology. 2013;209(4):358.e1-358.e4   Crossref logo
Link1 Link2

Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device±Metformin±weight loss in endometrial cancer (feMME) trial
Contemporary Clinical Trials. 2014;39(1):14-21   Crossref logo
Link1 Link2

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
Healthcare. 2017;5(3):30   Crossref logo

Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study
Journal of Gynecologic Oncology. 2019;30(2):   Crossref logo
Link1 Link2 Link3